Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
Immunotherapy is altering therapy methods for each limited- and extensive-stage small cell lung most cancers, defined Dr. Jacob A. Sands in an interview...
The FDA has accepted a brand new drug utility for relacorilant as a therapy for sufferers with platinum-resistant ovarian most cancers.The U.S. Meals...
Tania Chomiak-Salvi is among the many sufferers who has benefited from perioperative immunotherapy remedy for non-small cell lung most cancers. Photograph by Bob...
